CONSIDERATIONS TO KNOW ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Possessing identified the palmitoylation motif of APLNR, we designed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and infla